<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671254/" ref="ordinalpos=4246&amp;ncbi_uid=1721562&amp;link_uid=PMC2671254" image-link="/pmc/articles/PMC2671254/figure/F11-8010/" class="imagepopup">Figure 11.  From: Caveolin-1 (P132L), a Common Breast Cancer Mutation, Confers Mammary Cell Invasiveness and Defines a Novel Stem Cell/Metastasis-Associated Gene Signature. </a></div><br /><div class="p4l_captionBody">Results from pathway analysis with ASSESS. We also performed pathway analysis using ASSESS (analysis of sample set enrichment scores). Note that ER-α-, Wnt-, TGF-β-, and Rho GTPase-dependent signaling pathways all appear to be activated by Cav-1 (P132L), among others.</div></div>